Corporate Profile

Allosite Therapeutics is pioneering a significant shift in how the clinically validated integrin receptors are therapeutically targeted. We are developing allosteric activators as a new therapeutic modality for targeting integrins, and are also applying our robust, AI- and Machine-learning driven technology to develop first-in-class medicines.